Moyamoya disease - A rare vasculopathy in Europeans;Die Moyamoya-Erkrankung - Eine seltene Vasopathie bei europäischen Patienten

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 9, 2010, Pages 542-553

  Kramer M ^a   Berlit, P ^a  

^a ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BYPASS SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; HUMAN; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; VASCULAR DISEASE; CAUCASIAN; EUROPE; NOMENCLATURE;

CEREBRAL ANGIOGRAPHY; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MAGNETIC RESONANCE IMAGING; MOYAMOYA DISEASE; PROGNOSIS; TERMINOLOGY AS TOPIC;

EID: 77956672556     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245643     Document Type: Review

References (48)

1. Kraemer M, Heienbrok W, Berlit P. Moyamoya Disease in Europeans. Stroke 2008 39 3193-3200
2. Hoffman H J. Moyamoya disease and syndrome. Clin Neurol Neurosurg 1997 99 (Suppl 2) 39-44
3. Wakai K, Tamakoshi A, Ohno Y et al. Epidemiology of spontaneous occlusion of the circle of Willisi: results of national epidemiologic survey.The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual Report 1995. Ministry of Health and Welfare Japan Tokyo, Japan 1995 33-37
4. Achrol A S., Guzman R, Lee M et al. Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus 2009 26 pE4
5. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008 79 900-904
6. Chui D, Shedden P, Bratina P et al. Clinical features of moyamoya isease in the United States. Stroke 1998 29 1347-1351
7. Hallemeier C L., Rich K M., Grubb R L. et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006 37 1490-1496
8. Khan N, Schuknecht B, Boltshauser E et al. Moyamoya disease and moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir 2003 145 1061-1071
9. Khan N, Yonekawa Y. Moyamoya angiopathy in Europe. Acta Neurochir Suppl 2005 94 149-152
10. Khan N, Yonekawa Y. Moyamoya angiopathy in Europe: the beginnings in Zurich, practical lessons learned, increasing awareness and future perspectives. Acta Neurochir Suppl 2008 103 127-30
11. Hanggi D, Mehrkens J H., Schmid-Elsaesser R et al. Results of direct and indirect revascularisation for adult European patients with Moyamoya angiopathy. Acta Neurochir Suppl 2008 103 119-22
12. Czabanka M, Vajkoczy P, Schmiedek P et al. Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population. Neurosurg Focus 2009 26 E9
13. Vajkoczy P. Moyamoya disease: collateralization is everything. Cerebrovasc Dis 2009 28 258
14. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willisi (moyamoya disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997 2 238-240
15. Rafat N, Beck G Ch, Pena-Tapia P G. et al. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 2009 40 432-438
16. Inoue T K., Ikezaki K, Sasazuki T et al. DNA typing of HLA in the patients with moyamoya disease. Jpn J Hum Genet 1997 42 (4) 507-515 (Pubitemid 28104146)
17. Yamauchi T, Houkin K, Tada M et al. Familial occurrence of moyamoya disease. Clin Neurol Neurosurg 1997 99 162-167
18. Yamauchi T, Tada M, Houkin K et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willisi) to chromosome 17q25. Stroke 2000 31 930-935
19. Kuroda S, Iwasaki Y. Current review of familial moyamoya disease. ippon Rinsho 2006 64 750-754
20. Inoue T K., Ikezaki K et al. Linkage Analysis of Moyamoya Disease on Chromosome 6. J Child Neurol. 2000 15 179-182
21. Zafeiriou D I., Ikeda H, Anastasiou A et al. Familial moyamoya disease in a Greek family. Brain Dev 2003 25 (4) 288-290
22. Mineharu Y, Liu W, Inoue K et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 10 2008 70 (24 Pt 2) 2357-2363
23. Liu W, Hashikata H, Inoue K et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med 2009 19 1347-4715
24. Ikeda H, Sasaki T, Yoshimoto T et al. Mapping of a familial moyamoya disease gene to chromosome 3 p24.2-p26. Am J Hum Genet 1999 64 (2) 533-537
25. Inoue T K., Ikezaki K, Sasazuki T et al. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000 15 (3) 179-182
26. Kraemer M, Berlit P. Primary central nervous system vasculitis and moyamoya disease: similarities and differences. J Neurol 2009 257 816-819
27. Horn P, Lanczik O, Vajkoczy P et al. Hemodynamic reserve and high-intensity transient signals in moyamoya disease. Cerebrovasc Dis 2005 19 (3) 141-146
28. Tagawa T, Naritomi H, Mimaki T et al. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke 1987 18 (5) 906-910
29. Tagawa R, Naritomi H, Mimaki T et al. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke 1987 18 906-910
30. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008 7 1056-1066
31. Ishikawa T, Kuroda S, Nakayama N et al. Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir 2005 45 495-500; discussion 500
32. Papanagiotou P, Grunwald I Q., Politi M et al. Moyamoya disease. Radiologe 2005 45 466-470
33. Lee M, Zaharchuk G, Guzman R et al. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus 2009 26 E5
34. Perren F, Horn P, Vajkoczy P et al. Power Doppler imaging in detection of surgically induced indirect neoangiogenesis in adult moyamoya disease. J Neurosurg 2005 103 869-872
35. Umemura A, Yamada K, Masago A et al. Hemodynamic flow patterns evaluated by transcranial color-coded duplex sonography after STA-MCA bypass for internal carotid artery occlusion. Cerebrovasc Dis 2002 14 143-147
36. Iguchi Y, Kimura K, Tateishi Y et al. Microembolic signals are associated with progression of arterial lesion in moyamoya disease: a case report. J Neurol Sci 2007 260 253-255
37. Woitzik J, Horn P, Vajkoczy P et al. Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. J Neurosurg 2005 102 692-698
38. Huang A P., Liu H M., Lai D M. et al. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovasc Dis 2009 28 247-257
39. Kornblihtt L I., Cocorullo S, Miranda C et al. Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement. Stroke 2005 36 E71-E73
40. Rodriguez G J., Kirmani J F., Ezzeddine M A. et al. Primary percutaneous transluminal angioplasty for early moyamoya disease. J Neuroimaging 2007 17 48-53
41. Arita K, Kurisu K, Ohba S et al. Endovascular treatment of basilar tip aneurysms associated with moyamoya disease. Neuroradiology 2003 45 441-444
42. Touho H. Patch angioplasty to repair the arteriotomy defect in the wall of the middle cerebral artery after failure of superficial temporal artery-middle cerebral artery anastomosis in moyamoya disease case report. Neurol Med Chir 2002 42 435-438
43. Tezcan H, Yavuz S, Fak A S. et al. Coronary stent implantation in Behcets disease. Clin Exp Rheumatol 2002 20 704-706
44. Both M, Jahnke T, Reinhold-Keller E et al. Percutaneous management of occlusive arterial disease associated with vasculitis: a single center experience. Cardiovasc Intervent Radiol 2003 26 19-26
45. Liang P, Tan-Ong M, Hoffman G S. Takayasus arteritis: vascular interventions and outcomes. J Rheumatol 2004 31 102-106
46. Andrade J, Al A li A, Saw J et al. Acute stent thrombosis in a patient with giant cell arteritis. Can J Cardiol 2008 24 E25-E26
47. Kobayashi E, Saeki N, Oishi H et al. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 2000 93 976-980
48. Kuroda S, Hashimoto N, Yoshimoto T et al. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 2007 38 1430-1435